2019 AAPB Webinar 4: Addressing Opioid Addiction using Advanced Neuromodulation Techniques
Available for download after purchase
The purpose of this research was to determine if neuromodulation techniques (tDCS, tACS, tRNS and pEMF) have clinical utility on patients undergoing the first five days of a opioid rehabilitation detoxification program. 52 patients (39 males, 13 females) were in the “Stimulation Only” group and were compared to 45 patients (30 males, 15 females) in the “Neurofeedback Only” group. Patients in the stimulation only group demonstrated significantly more changes in the EEG in the alpha, beta, beta1, beta2, beta3, high beta and gamma frequency bands as compared to the neurofeedback only group that showed changes in the alpha band. The stimulation only group reported significant reduction in anxiety and improved sleep from day one to day five of the treatment program. PHQ-9 and GAD-7 Norm referenced scales showed significant improvements in both anxiety and depression symptoms. These results suggest that neuromodulation modalities have clinical utility on patients who participate in a detoxification program that utilizes neuromodulation during the first five days of detoxification.
Professionals who complete this webinar will be able to:
- Develop a basic understanding of tDCS, tACS, tRNS and pEMF mechanisms of action.
- Develop a basic understanding of the impact of tDCS, tACS, tRNS and pEMF on the EEG.
- Develop a basic understanding of opioid detoxification symptoms and medical interventions.
- Develop a basic understanding of how neurostimulation compares to neurofeedback in the first five days of detox.
- Develop a basic understanding of how neuromodultation reduces symptoms of depression and anxiety in detox.
Who Should Attend: Anyone interested in methods to enhance or improve the effectiveness of substance abuse detoxification programs. Anyone interested in neuromodulation.